CSN Login
Members Online: 3

You are here

CSN Home › Discussion boards › Cancer specific › Colorectal Cancer

PX-866 with Cetuximab (Erbitux) going into Phase Two

coloCan
Posts: 1956
Joined: Oct 2009
May 24, 2011 - 9:41 pm

"PX-866 is a pan inhibitor of the PI-3K/PTEN/AKT pathway, a critical cell signalling that is activated in many types of cancer"-(CRC being one of them)
Its made by Oncothyreon Inc and I read about it at prenewswire.com

with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions

Subscribe to Comments for "PX-866 with Cetuximab (Erbitux) going into Phase Two"

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2019 © Cancer Survivors Network